Prise en charge des masses annexielles organiques : résultats d’une enquête de pratique

Huchon, Cyrille; Bats, Anne-Sophie; Bensaïd, C.; Junger, M.; Nos, Claude; Châtellier, Gilles; Lécuru, Fabrice

doi:10.1016/j.gyobfe.2008.08.014

Cited by 18 publications

(8 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A taxa de conversão em laparotomia das laparoscopias realizadas neste estudo (31%) foi superior à encontrada frequentemente na literatura, situada ao redor de 10% 12,13,25,26 . Essa diferença está relacionada ao fato de outros estudos reportarem populações que incluem todo tipo de cirurgia laparoscópica, enquanto neste estudo focamos apenas em procedimentos de alta e média complexidade utilizados no tratamento de tumores anexiais, associado ao fato de que 18% de nossas laparoscopias seriam convertidas em laparotomia de qualquer maneira, pela presença de um tumor maligno.…”

Section: Discussionunclassified

Laparoscopia na abordagem inicial de tumores anexiais

Barreta¹,

Bastos²,

Sarian³

et al. 2014

Rev. Bras. Ginecol. Obstet.

View full text Add to dashboard Cite

This study suggests that laparoscopy for the diagnosis and treatment of adnexal masses is safe and does not increase complication rates even in patients who need conversion to laparotomy. However, when doubt about the safety of the procedure and about the presence of malignancy persists, consultation with an expert gynecology-oncologist with experience in advanced laparoscopy is recommended. A large tumor diameter was associated with the necessity of conversion to laparotomy.

show abstract

Section: Discussionunclassified

Laparoscopia na abordagem inicial de tumores anexiais

Barreta¹,

Bastos²,

Sarian³

et al. 2014

Rev. Bras. Ginecol. Obstet.

View full text Add to dashboard Cite

show abstract

“…СА-125 в сыворотке не повышается вовсе [7,8]. Согласно исследованию C. Huchos с соавт., проведенному во Франции, показания к хирургическому вмешательству основываются прежде всего на размерах опухоли и ультразвуковых данных [9]. При этом было доказано, что УЗ-характеристика ОЯ имеет недостаточные возможности стратификации рисков злокачественности и в ряде случаев, с одной стороны, приводит к ненужной хирургической резекции или некорректному объему оперативных вмешательств опухолевидных/доброкачественных образований и длительному наблюдению за пограничными/злокачественными новообразованиями, с другой [10].…”

Section: введение / Introductionunclassified

О-RADS and ADNEX MR scoring system: standardization of assessment and modern approaches to stratification of ovarian malignancy risks

Solopova

Dudina

2020

Akušerstvo, ginekologiâ i reprodukciâ

View full text Add to dashboard Cite

This article reviews the studies published over the recent 10 years about diagnostic imaging of ovarian lesions (OL). We discuss the current classification systems considering the imaging criteria and the risks of malignancy as well as the ways of optimizing the treatment of patients. There are a number of methods of evaluation and interpretation of diagnostic data obtained using ultrasound as a first line method for OL visualization. To report the results, there is a unified terminology system O-RADS (Ovarian-Adnexal Reporting and Data System) developed specifically for ultrasound examinations. In 2013, the ADNEX MR (adnexal lesions magnetic resonance imaging) scoring system (AMRSS) was developed to standardize magnetic resonance data. That system combines the analysis of both basic-anatomical and functional MR-images and allows one to classify ovarian tumors by the risk of malignancy. Although O-RADS and AMRSS are based on different diagnostic modalities, they complement each other for the diagnostic purpose. In this review, we analyze correlations between the results obtained with these two methods; we also address the possibility of using the above methods in combination in order to pursue a more comprehensive approach to diagnosis of ovarian cancer.

show abstract

“…Devido à dificuldade de diagnóstico pré-operatório de malignidade, uma em cada dez mulheres será submetida à cirurgia por um tumor anexial durante sua vida. Entre elas, em apenas 17% haverá um tumor anexial maligno 3 . Atualmente, o padrão-ouro para diferenciação entre tumores anexiais benignos e malignos é a determinação do tipo histológico no exame microscópico em parafina.…”

Section: Introductionunclassified